Y. Jaimes

Dynamic changes in RAS gene status in circulating tumour DNA: a phase II trial of first-line FOLFOXIRI plus bevacizumab for RAS-mutant metastatic colorectal cancer (JACCRO CC-11)

M. Takeuchi, K. Danenberg, P. Danenberg, 2022, ESMO open.

Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types.

J. Pinski, Y. Elshimali, A. Barzi, 2018, Biochemical and biophysical research communications.

P2.03b-039 Cell-Free (cf) DNA and cfRNA levels in Plasma of Lung Cancer Patients Indicate Disease Status and Predict Progression: Topic: Biomarkers

K. Danenberg, P. Danenberg, L. Raez, 2017 .

Correlation of cell-free circulating DNA, RNA, and PD-L1 from plasma with clinical response in patients with metastatic lung and breast cancers.

K. Danenberg, P. Danenberg, L. Raez, 2017 .

Gene mutation status in circulating tumor DNA (ctDNA) and first-line FOLFOXIRI plus bevacizumab (bev) in metastatic colorectal cancer (mCRC) harboring RAS mutation.

H. Lenz, M. Takeuchi, K. Danenberg, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.